Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factors » significant predictors (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factors » significant predictors (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
-
261
-
262
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
263
-
264
-
265
-
266
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
267
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
268
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
269
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
270
-
271
-
272
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
273
-
274
-
275
-
276
-
277
-
278
-
279
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
280